Alaunos Therapeutics Newsroom

Alaunos Therapeutics | 10-Q: Q2 2024 Earnings Report

SECAug 15 04:56 · Announcements

Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

BenzingaJul 19 01:19

Alaunos Therapeutics Shares Are Trading Lower After the Company Announced a 1-for-10 Reverse Stock Split.

BenzingaJul 19 00:13

Tuesday, Alaunos Therapeutics Announced A Reversed Stock Split Of 1-for-10, Effective July 18-8K

BenzingaJul 18 17:01

Express News | Alaunos Therapeutics: Filed 3Rd Amended & Restated Certificate of Incorporation to Effect Reverse Stock Split of Common Stock at Ratio of 1-for-10

BreakingsJul 17 18:08

12 Health Care Stocks Moving In Thursday's Intraday Session

BenzingaJun 21 00:32

BioSig Technologies Appoints Ferdinand Groenewald as Interim CFO

MT NewswiresJun 10 22:43

Alaunos Therapeutics (TCRT.US): The 2024 Q1 financial report achieved revenue of $1,000, previous value of $0; earnings per share of -0.11 dollars, previous value of -0.63 dollars.

Alaunos Therapeutics (TCRT.US): The 2024 Q1 financial report achieved revenue of $1,000, previous value of $0; earnings per share of -0.11 dollars, previous value of -0.63 dollars.

Zhitong FinanceMay 16 06:50

Alaunos Therapeutics | 10-Q: Q1 2024 Earnings Report

SECMay 15 21:00 · Announcements

Alaunos Therapeutics Announces Executive Financial Leadership Changes

TipRanksFeb 23 06:10

Alaunos Therapeutics Regains Nasdaq Listing Compliance

TipRanksFeb 21 05:28

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

BenzingaFeb 14 21:05

TCRT, NXT and MINM Among Mid-day Movers

Seeking AlphaFeb 2 01:36

Alaunos Therapeutics To Carry Out 1-for-15 Reverse Stock Split On February 1st, 2024

January 30th - $Alaunos Therapeutics(TCRT.US)$ is about to implement a 1-for-15 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from February 1st, 2024.$Alaunos

Futu NewsJan 30 08:40

Alaunos Therapeutics Appoints Dale Curtis Hogue As Interim CEO, Effective Jan. 20 2024; Hogue Will Continue Serving On The Board

BenzingaJan 23 05:38

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaJan 19 21:06

12 Health Care Stocks Moving In Monday's After-Market Session

BenzingaJan 16 05:30

12 Health Care Stocks Moving In Friday's Intraday Session

BenzingaJan 6 01:31

On December 22, 2023, Alaunos Therapeutics Entered Into Separation And Release Agreement With CEO Kevin Boyle In Connection With Boyle's Termination - Filing

BenzingaDec 29, 2023 05:39

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaDec 19, 2023 21:07